J Korean Med Assoc Search


J Korean Med Assoc > Volume 48(12); 2005 > Article
Journal of the Korean Medical Association 2005;48(12):1173-1178.
DOI: https://doi.org/10.5124/jkma.2005.48.12.1173   
Clinical Significance of Fasting Glucose Criteria in Metabolic Syndrome
Kyong Soo Park
Department of Internal Medicine, Seoul National University College of Medicine and Hospital, Korea. kspark@snu.ac.kr
Both Adult Treatment Panel III(ATP III) and International diabetes Federation(IDF) adopted impaired fasting glucose (IFG) as one of the criteria for identifying individuals with metabolic syndrome. However, many studies have shown that IGT is a better predictor of cardiovascular disease(CVD) than IFG. Recently the American Diabetes Association(ADA) revised the diagnostic criteria for IFG, lowering the diagnostic threshold from 110 mg/dL to 100 mg/dL to improve the alignment of IFG and IGT. Although the revised definition of IFG increases the prevalence of metabolic syndrome as well as that of IFG, relative risk of CVD is still lower than that of IGT. The clinical and public health implications of the revised IFG definition remain to be elucidated.
Key Words: Impaired Fasting Glucose(IFG), Impaired Glucose Tolerance(IGT), Metabolic Syndrome, Cardiovascular Risk


Browse all articles >

Editorial Office
Samgu B/D 7F, 40 Cheongpa-ro, Youngsan-gu, Seoul 04373, Korea
Tel: +82-1566-2844    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2022 by Korean Medical Association.

Developed in M2PI

Close layer
prev next